I think this is a good move by management because it should reduce short term volatility in the stock. Institutional shareholders generally don't like short term volatility and I think it's a reason there are so few instos on the register for what is now a $1bn+ market cap stock (the relatively low liquidity has also kept the instos away, although that it starting to improve).
No more 1/4 dose sales, page-10
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.5¢ | $40.71K | 229.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2141678 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 2268400 | 21 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |